Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
NYSE:EW
Price:
92.535
USD
0.57%
Market Closed
Market Cap:
$53.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Edwards Lifesciences Corp
NYSE:EW
|
US |
|
Asuransi Bina Dana Arta Tbk PT
IDX:ABDA
|
ID |
Wall St Price Targets
EW Price Forecast
Based on 32 analysts
Based on 32 analysts
+11% Upside
from
$92.535
today
Edwards Lifesciences Corp (EW)’s 12-month stock price forecast through November 2027 has a consensus target of $102.51, implying 11% upside. The forecast is based on price targets from 32 Wall Street analysts.
EW Analyst Rating
Based on 30 analysts
Based on 30 analysts
Analysts rate EW Buy, with 23 of 30 recommending Buy or Strong buy.
Edwards Lifesciences Corp Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EW's stock price target?
Price Target
102.51
USD
102.51
USD
According to Wall Street analysts, the average 1-year price target for EW is 102.51 USD with a low forecast of 85.85 USD and a high forecast of 122.85 USD.
What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.
What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.
What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%
28%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.
What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
20%
20%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.